The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Wed., Apr. 24, 3:55 PM

Slide #38. Catalent, Inc. Paragon Bioservices, Inc.

Acquirer: Catalent, Inc. (NYSE:CTLT)
Acquiree: Paragon Bioservices, Inc.
Details: Catalent, Inc. (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies, today announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.

Catalent is a holding company. Co. is a provider of delivery technologies and development solutions for drugs, biologics and consumer and animal health products. Co.'s segments include: Softgel Technologies, which provides formulation, development, and manufacturing services for soft capsules; Biologics and Specialty Drug Delivery, which provides development and delivery technologies and integrated solutions; Oral Drug Delivery, which provides various formulation development and manufacturing technologies; and Clinical Supply Services, which provides manufacturing, packaging, storage, distribution, project management, and inventory management for drugs and biologics in clinical trials.

CTLT SEC Filing Email Alerts Service

Open the CTLT Page at The Online Investor »

Company Name:  Catalent Inc
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding CTLT:  64
Total Market Value Held by ETFs:  $1.03B
Total Market Capitalization:  $6.47B
% of Market Cap. Held by ETFs:  15.94%

Open the CTLT Page at The Online Investor (in a new window) »

April 24, 2019    3:55 PM Eastern
Quotes delayed 20 minutes

Strong Buy (3.59 out of 4)
67th percentile
(ranked higher than approx. 67% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions | | Copyright © 1998 - 2019, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.